Katherine Scherping (TBCH) files Rule 144 notice listing restricted shares, recent sale

Rhea-AI Filing Summary

Katherine Scherping filed a Rule 144 notice reporting proposed sales of Common Stock. The filing lists multiple tranches of Restricted Stock dated 04/01/2023 (5,478), 04/01/2024 (9,281), and 04/01/2025 (5,143) linked to the issuer. The filing also reports securities sold in the past three months: 98 Common shares on 03/20/2026 with an associated figure of 1127.00.

Insights

Securities Compliance Analyst

Rule 144 filing lists restricted stock tranches and a recent small sale.

The notice records restricted Common shares dated 04/01/2023 (5,478), 04/01/2024 (9,281), and 04/01/2025 (5,143). It also documents a sale of 98 Common shares on 03/20/2026 with an associated figure of 1127.00.

Cash‑flow treatment and whether the listed restricted shares are being offered now are not stated in the excerpt; subsequent filings or broker confirmations would clarify execution and proceeds.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	19902	231221.44	19600044	03/23/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/01/2025	Restricted Stock	Issuer			5143	04/01/2025	Not Applicable
Common	04/01/2024	Restricted Stock	Issuer			9281	04/01/2024	Not Applicable
Common	04/01/2023	Restricted Stock	Issuer			5478	04/01/2023	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
KATHERINE SCHERPING 15822 Bernardo Center Drive, Suite 105 San Diego CA 92127	Common	03/20/2026	98	1127.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the TBCH Form 144 filed by Katherine Scherping report?

It reports proposed sales and restricted stock tranches: 5,478 (04/01/2023), 9,281 (04/01/2024), and 5,143 (04/01/2025). The filing also notes a recent sale of 98 shares on 03/20/2026. Additional execution details are not included in the excerpt.

How many shares were sold in the past three months in the TBCH filing?

The filing shows 98 Common shares sold on 03/20/2026 associated with the figure 1127.00. The excerpt does not provide buyer identity or net proceeds details.

Which restricted stock grant dates and sizes are listed in the filing?

The restricted stock entries listed are dated 04/01/2023 (5,478), 04/01/2024 (9,281), and 04/01/2025 (5,143). These figures appear under "Securities To Be Sold."

Who is the broker or intermediary named on the Form 144?

The excerpt names Morgan Stanley Smith Barney LLC Executive Financial Services at 1 New York Plaza, suggesting broker involvement. The filing does not specify the exact role or confirm execution details.

Does the filing state the cash proceeds the issuer or seller will receive?

The excerpt does not state proceeds received by the issuer or seller. It lists share counts and a figure of 1127.00 linked to the recent sale, but no explicit proceeds recipient or gross/net proceeds breakdown is provided.